Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Prognostic Role of LA Strain in Acute Myocardial Infarction
A clinical trial update assessing whether left atrial strain has prognostic value in patients with acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Myocardial Ischemia and Transfusion [Phase 3]
Phase 3 clinical trial update on transfusion in patients with myocardial infarction and anemia; the Rutgers-sponsored study has completed an…
-
FDA approval · 2024-05-09FDA Approved: EPTIFIBATIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application (ANDA) for a generic version of eptifibatide (Integrilin). The approval permits …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: The Impact of Phase I Cardiac Rehabilitation on the Prognosis of AMI Patients After PCI [NA]
This clinical trial update reports that a study evaluating the impact of Phase I cardiac rehabilitation on prognosis after PCI in patients w…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Cardiac Troponin Fragmentation After Heavy Physical Exercise The MaraCat2 Study
An ongoing study (MaraCat2) from the University of Turku is evaluating cardiac troponin fragmentation after heavy physical exercise, with en…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Mechanocardiography in Patients With STEMI
This is a clinical trial update from the University of Turku about using mechanocardiography in patients with acute myocardial infarction. T…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Improving Cardiac Secondary Prevention [NA]
Clinical trial update from Western University (Canada) on improving cardiac secondary prevention after myocardial infarction. The study is c…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD) [NA]
This clinical trial entry describes PROTECT-ICD, a study evaluating whether programmed ventricular stimulation can identify acute myocardial…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: CES1 Crossover Trial of Clopidogrel and Ticagrelor [Phase 4]
Phase 4 crossover trial comparing clopidogrel and ticagrelor in patients with myocardial infarction and thrombotic disorders; results have b…
-
CLINICAL_TRIALS withdrawal · 2024-05-02Clinical Trial Update: Inflammatory Cell Trafficking After Myocardial Infarction [NA]
A clinical trial investigating inflammatory cell trafficking after myocardial infarction has been withdrawn from the registry. The sponsor l…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
The PRESTO trial evaluates pre-hospital troponin testing for patients with chest pain and suspected acute coronary syndrome; the study is cu…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Effect of Omega 3 Fatty Acids on Vascular Function [NA]
Clinical trial update examining the effect of omega-3 fatty acids on vascular function in people with a history of myocardial infarction.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Construction of a Prediction Model for MACCE in Elderly Patients After Elective Non-cardiac Surgery
A clinical trial aims to develop a predictive model for major adverse cardiac events and stroke in elderly patients undergoing elective non-…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Warning Model of Myocardial Remodeling After Acute Myocardial Infarction Using Multimodal Feature Structure Technology
A clinical trial update on a warning model of myocardial remodeling after acute myocardial infarction using multimodal feature structure tec…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Genetics of Hypertension Associated Treatments (GenHAT)
GenHAT is a genetics-focused clinical trial examining how genetic variation influences responses to hypertension treatments; the study statu…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: UC-MSC Transplantation for Left Ventricular Dysfunction After AMI [Phase 1]
Phase 1 clinical trial evaluating transplantation of umbilical cord-derived mesenchymal stem cells (UC-MSC) for left ventricular dysfunction…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: LV Thrombus After Acute AMI: A Randomized Controlled Trial [NA]
A randomized controlled trial evaluating left ventricular thrombus after acute myocardial infarction has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration [Phase 1, Phase 2]
Phase 1/2 trial investigating allogeneic heart stem cells for myocardial regeneration in myocardial infarction; study terminated with posted…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction [Phase 3]
Phase 3 trial update for empagliflozin assessing its ability to prevent worsening of left ventricular volumes and systolic function after my…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) [Phase 3]
Phase 3 clinical trial evaluating metformin for prevention of cardiovascular events in patients with acute myocardial infarction and prediab…
-
FDA approval · 2024-03-29FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol by Aurobindo Pharma Limited, granting approval of a generic version under the ANDA proc…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction) [Phase 1, Phase 2]
Phase 1/2 clinical trial update for MiSaver stem cell treatment in myocardial infarction completed.
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for atenolol from Unichem Pharmaceuticals USA, Inc., granting an additional approval related to the …
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol by Ipca Laboratories Limited.
-
EMA approval · 2024-03-26EMA Authorised: Clopidogrel ratiopharm (clopidogrel (as hydrogen sulfate)) — Teva B.V.
European Medicines Agency authorises Clopidogrel ratiopharm (clopidogrel hydrogen sulfate) for multiple cardiovascular indications including…